| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |